Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study

Jing Qin, Chong You, Qiushi Lin, Taojun Hu, Shicheng Yu, Xiao-Hua Zhou
doi: https://doi.org/10.1101/2020.03.06.20032417
Jing Qin
1Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, Maryland, United States, 20852
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chong You
2Beijing International Center for Mathematical Research, Peking University, China, 100871
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiushi Lin
2Beijing International Center for Mathematical Research, Peking University, China, 100871
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taojun Hu
3School of Mathematical Sciences, Peking University, China, 100871
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shicheng Yu
5Office for Epidemiology, Chinese Center for Disease Control and Prevention, China, 102206
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Hua Zhou
2Beijing International Center for Mathematical Research, Peking University, China, 100871
4Department of Biostatistics, School of Public Health, Peking University, China, 100871
6Center for Statistical Science, Peking University, China, 100871
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: azhou@math.pku.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in recent published studies, but all have their own limitations. In this study, we propose a novel low-cost and accurate method to estimate the incubation distribution.

Methods We have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from Wuhan and then following them until their symptoms developed. The renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. Under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. Such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data.

Findings The estimated distribution of forward time fits the observations in the collected data well. The estimated median of incubation period is 8·13 days (95% confidence interval [CI]: 7·37-8·91), the mean is 8·62 days (95% CI: 8·02-9·28), the 90th percentile is 14·65 days (95% CI: 14·00-15·26), and the 99th percentile is 20·59 days (95% CI: 19·47, 21·62). Compared with results in other studies, the incubation period estimated in this study is longer.

Interpretation Based on the estimated incubation distribution in this study, about 10% of patients with COVID-19 would not develop symptoms until 14 days after infection. Further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods.

Funding This research is supported by National Natural Science Foundation of China grant 8204100362 and Zhejiang University special scientific research fund for COVID-19 prevention and control.

Evidence before this study Before the current outbreak of coronavirus disease (COVID-19) in China, there were two other coronaviruses that have caused major global epidemics over the last two decades. Severe acute respiratory syndrome (SARS) spread to 37 countries and caused 8424 cases and 919 deaths in 2002-03, while Middle East respiratory syndrome (MERS) spread to 27 countries, causing 2494 cases and 858 deaths worldwide to date. Precise knowledge of the incubation period is crucial for the prevention and control of these diseases. We have searched PubMed and preprint archives for articles published as of February 22, 2020, which contain information about these diseases by using the key words of “COVID-19”, “SARS”, “MERS”, “2019-nCoV”, “coronavirus”, and “incubation”. We have found 15 studies that estimated the distribution of the incubation period. There are four articles focused on COVID-19, five on MERS, and six on SARS. Most of these studies had limited sample sizes and were potentially influenced by recall bias. The estimates for mean, median, and percentiles of the incubation period from these articles are summarized in Table 1.

Added value of this study In the absence of complete and robust contact-tracing data, we have inferred the distribution of the incubation period of COVID-19 from the durations between departure from Wuhan and symptom onset for the confirmed cases. More than 1000 cases were collected from publicly available data. The proposed approach has a solid theoretical foundation and enhances the accuracy of estimation by reducing recall bias and utilizing a large pool of samples.

Implications of all the available evidence Based on our model, about 10% of patients with COVID-19 do not develop symptoms until 14 days after infection. Further study of individuals with long incubation periods is warranted.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research is supported by National Natural Science Foundation of China grant 8204100362 and Zhejiang University special scientific research fund for COVID-19 prevention and control.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

data is available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 10, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
Jing Qin, Chong You, Qiushi Lin, Taojun Hu, Shicheng Yu, Xiao-Hua Zhou
medRxiv 2020.03.06.20032417; doi: https://doi.org/10.1101/2020.03.06.20032417
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
Jing Qin, Chong You, Qiushi Lin, Taojun Hu, Shicheng Yu, Xiao-Hua Zhou
medRxiv 2020.03.06.20032417; doi: https://doi.org/10.1101/2020.03.06.20032417

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (143)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (172)
  • Epidemiology (4904)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (85)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5405)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1831)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)